Benicar is an antihypertensive drug that has Olmesartan active substance.This oral medication is indicated for the treatment of individuals with high blood pressure.It blocks the vasoconstricting effects of an enzyme called angiotensin.
How To Use Benicar
Take 20 mg once daily, but if the blood pressure is too high, the dose may be increased to 40 mg once daily.
Side Effects What evils Benicar Can Cause Me?
The most common side effects are dizziness, belly pain, nausea, vomiting, cough, kidney problems, redness of the skin, itching or swelling of the face, headache, changes in blood test values, muscle aches, weakness, tiredness and indisposition
Contraindications;When should I not use it?
It should not be used by children or adolescents under the age of 18 years, pregnant women and by people with allergy to any component of the formula.
Mechanism Of Action How It Works?
Benicar contains in its formula olmesartan medoxomil, a substance that lowers blood pressure by increasing the loss of water through the urine and causing the blood vessels to become wider for the blood to pass easily.
Warnings and Precautions;What should I know before using it?
This medicine should be used with caution during breastfeeding and in patients with kidney problems. Due to the loss of salt by the urine, during the treatment one must take into account the values of salt in the organism to verify if there is not very great decrease of its concentration.
Overdose;What to do if someone uses more than the indicated amount?
If you take a dose higher than indicated, you may experience a drop in blood pressure with dizziness, poor mood and loss of strength. Call your doctor as soon as possible.
Pharmacological Characteristics
Olmesartan Medoxomila (active substance) is chemically described as 2,3-dihydroxy-2-butenyl-4- (1-hydroxy-1-methylethyl) -2-propyl-1- [p- (o-1H-tetrazol-5 -yl-phenyl) benzyl] imidazole-5-carboxylate, cyclic 2,3-carbonate. Its empirical formula is C 29 H 30 N 6 0 6 .
It is a prodrug which, during absorption through the gastrointestinal tract, is hydrolyzed to olmesartan, the biologically active compound. It is a selective antagonist of the angiotensin II receptor subtype AT 1 .
